Razzaki TS, Weiner A, Shukla AP Therapeutics and Clinical Risk Management 2022, 18:955-964 Published Date: 28 September 2022 Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview Telci Caklili O, Cesur M, Mikhailidis DP, Rizzo M Diabetes, Metabolic Syndrome and Obesity 2023, 16:1767-1774 Published Date: 14 June 2023 The Effect of Tirzepatide on Weight, Lipid Metabolism and Blood Pressure in Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis Lv X, Wang H, Chen C, Zhao Y, Li K, Wang Y, Wang L, Fu S, Liu J Diabetes, Metabolic Syndrome and Obesity 2024, 17:701-714 Published Date: 12 February 2024 Analysis Using Various Models on the Effect of Metabolic Surgery on Cardiovascular Disease Risk in the Chinese Population with Obesity Wang Z, Xu G, Chen G, Amin B, Wang L, Li Z, Wang J, Chen W, Yu C, Tian C, Wuyun Q, Sang Q, Shang M, Lian D, Zhang N Diabetes, Metabolic Syndrome and Obesity 2024, 17:2457-2468 Published Date: 17 June 2024 Real-World Effectiveness and Safety of Tirzepatide, Semaglutide, and Liraglutide in Adults with Overweight or Obesity without Diabetes: A Comparative Study Cetiner S Diabetes, Metabolic Syndrome and Obesity 2026, 19:594898 Published Date: 31 March 2026
Connect with a qualified healthcare practitioner to learn more
At 9 months after surgery, a telephone follow-up indicated that the patient was in good condition without any signs of tumour recurrence or metastasis, and the patient said, After surgical treatment, my abdominal pain and abdominal distention disappeared
D.DannenmaierS.DrepperF.et al
10 Without behavior change, most of the lost weight will come back within 12 months of stopping the medication
This allows the peptide to circulate throughout the body, triggering deep-layer cellular repair and reaching hair follicles that topicals often cannot penetrate
